Department of Plastic and Aesthetic Surgery, First Affiliated Hospital of Guangxi Medical University, GuangXi, China.
Department for Plastic, Reconstructive, and Aesthetic Surgery, Hand Surgery, Fachklinik Horneide, Münster, Germany.
Aesthet Surg J. 2022 Mar 15;42(4):370-377. doi: 10.1093/asj/sjab197.
Because breast augmentation is one of the most popular cosmetic procedures, the issue of implant-related complications has been widely debated ever since the FDA approved the use of implants in 1962. Although decades have passed, breast implant illness (BII) still represents a poorly defined and controversial complication. With ongoing nonscientific discussion in the mainstream media and on social media, revealing the etiology of BII is urgent because knowledge of this subject ultimately influences patients' decisions. Little or no scientific research is currently available on BII and no final conclusions regarding its etiology, clinical manifestations, diagnostic criteria, or treatment have been made. This review aims to give an overview of the hypotheses on the etiology of BII and seeks inspiration to improve the conditions of BII patients.
由于隆胸是最受欢迎的美容手术之一，自 1962 年 FDA 批准使用植入物以来，有关植入物相关并发症的问题一直备受争议。尽管已经过去了几十年，但乳房植入物疾病（BII）仍然是一种定义不明确且存在争议的并发症。由于对这一主题的了解最终会影响患者的决策，因此，在主流媒体和社交媒体上持续进行非科学讨论，揭示 BII 的病因迫在眉睫。目前，关于 BII 的科学研究很少，也没有关于其病因、临床表现、诊断标准或治疗的最终结论。本综述旨在概述 BII 的病因假说，并寻求灵感以改善 BII 患者的状况。
